Latest Leverage News

Lithium Plus Minerals Limited (ASX: LPM) reported significant progress on its Lei Lithium Development with advancing environmental approvals and infrastructure design, while its Wingate Project reveals promising large-scale gold potential. The company maintains a solid cash position of AUD 3.6 million as it prepares for upcoming exploration campaigns.

Cadoux Limited has made significant progress in its High Purity Alumina and Minhub rare earth projects during Q1 2025, advancing engineering studies, securing key contracts, and strengthening ESG initiatives while preparing for commercialisation.

Blackstone Minerals has entered a binding agreement to merge with IDM International, acquiring the high-grade Mankayan copper-gold project in the Philippines. This strategic move positions Blackstone at the forefront of critical metals and precious metals markets amid growing global demand.

Nimy Resources has defined a high-grade gallium Exploration Target in Western Australia and secured strategic partnerships to support supply to the US Department of Defense, positioning itself strongly in the critical minerals sector.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

DGR Global Limited reported steady progress in project generation and strategic investments during Q1 2025, while navigating ongoing legal challenges and securing a $23.5 million funding facility to support operations and refinancing.

RooLife Group reported a strategic quarter marked by the launch of its TikTok UK marketplace, expansion of its own health product range, and a significant capital raise backed by a key Chinese partner.

Reedy Lagoon Corporation has completed an extensive FineFraction soil sampling program across four gold prospects at Burracoppin, while seeking a farm-in partner for its iron project and maintaining a cautious cash position.

FBR Limited wraps up its US Demonstration Program, secures $6.3 million in capital, and appoints Mark Pivac as CEO amid a 70% cost reduction drive. Strategic collaborations with Samsung Heavy Industries and Liebherr signal broader automation ambitions.

Clarity Pharmaceuticals reports a robust cash position and strategic refocus on its lead prostate cancer asset, Cu-SAR-bisPSMA, supported by multiple FDA Fast Track designations and advancing clinical trials.

Invion Limited has progressed its Photosoft clinical programs with new patient dosing and an expanded collaboration with Hanlim Pharm, backed by a successful $2 million share placement to accelerate development.

Stonehorse Energy’s Q1 2025 report reveals Canadian wells outperforming production forecasts while revenue dips due to softer commodity prices. US operations show recovery, and the company intensifies Canadian business development amid market volatility.